Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

HYDROcodone-chlorpheniramine

HYDROcodone-chlorpheniramine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
TussiCaps CAPSULE, EXTENDED RELEASE, ORAL 5 mg-4 mg, 10 mg-8 mg    
Vituz LIQUID, ORAL 5 mg-4 mg/5 mL    
Tussionex PennKinetic SUSPENSION, EXTENDED RELEASE, ORAL 10 mg-8 mg/5 mL      

VIEW MORE Antitussives
CLASS
480800

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

HYDROcodone-chlorpheniramine (TussiCaps)

  • 5 mg-4 mg extended release capsule oral 1 capsule q 12 hrs      
  • 10 mg-8 mg extended release capsule oral 1 capsule q 12 hrs

HYDROcodone-chlorpheniramine (Tussionex PennKinetic)

  • 10 mg-8 mg/5 mL extended release suspension oral 2.5 mL q 12 hrs
  • 10 mg-8 mg/5 mL extended release suspension oral 5 mL q 12 hrs
 Interchange the TUSSICAPS capsules to an equivalent dose of the TUSSIONEX liquid.

HYDROcodone-chlorpheniramine (Vituz)    

  • 5 mg-4 mg/5 mL liquid oral

HYDROcodone-chlorpheniramine (Tussionex PennKinetic)

  • 10 mg-8 mg/5 mL extended release suspension oral

Vituz dosed as q6hrs. Tussionex dosed as q12 hrs.

Interchange at the same total daily dose, but divided into 2 doses (q12h) instead of 4 doses (q6h).


Tussionex PennKinetic medication guide

Vituz medication guide


Reviewed: December 16, 2008 and February 25, 2014 (Vituz)


Last updated: Aug. 21, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.